WHO & Regional Offices [to 08 Jan 2022]

WHO & Regional Offices [to 08 Jan 2022]
https://www.who.int/
Selected News, Statements
23 December 2021
Departmental news
Achieving 70% COVID-19 Immunization Coverage by Mid-2022
[See Perspectives above for full text]

22 December 2021
Statement
Interim statement on booster doses for COVID-19 vaccination

22 December 2021
News release
From vaccines to vaccinations: seventh meeting of the Multilateral Leaders Task Force on COVID-19 Vaccines, Therapeutics and Diagnostics

21 December 2021
Departmental news
US FDA approved cabotegravir extended-release – the first long-acting injectable option for HIV pre-exposure prophylaxis

21 December 2021
Departmental news
WHO lists 10th COVID-19 vaccine for emergency use : Nuvaxovid

20 December 2021
Departmental news
Latest child mortality estimates reveal world remains off track to meeting Sustainable Development Goals

20 December 2021
Departmental news
Novavax Covid-19 vaccine recommendations for use

::::::

 

WHO Regional Offices
Selected Press Releases, Announcements
WHO African Region AFRO
:: Meningitis outbreak in Democratic Republic of the Congo declared over 24 December 2021

WHO Region of the Americas PAHO
:: 29 Dec 2021 COVID-19 cases increase 50% in the Americas in the last week
The region reports the biggest rise in cases worldwide with holiday period set to drive up numbers, PAHO warns, urging countries to continue vaccination campaigns and implementation of public health measures. Washington, DC, December 29, 2021 (PAHO)- Pan American Health Organization (PAHO) data show that COVID-19 cases increased 50% and deaths 11…
:: 23 Dec 2021 PAHO welcomes first WHO emergency use listing of COVID-19 vaccine produced in Latin America
Approval will increase vaccine availability as pandemic persists Washington, D.C., 23 December 2021 (PAHO) – The Pan American Health Organization (PAHO) welcomed the WHO listing today of an AstraZeneca vaccine jointly produced by Argentina and Mexico – the first such decision for a COVID-19 vaccine manufactured in Latin America. The vaccine,…

WHO South-East Asia Region SEARO
:: 8 January 2022 News release Strict implementation of public health and social measures a must to arrest the surge: WHO

WHO European Region EURO
No new digest content identified

WHO Eastern Mediterranean Region EMRO
:: German donation supports nationwide monitoring of COVID-19 variants in Islamic Republic of Iran
6 January 2022
:: Statement by WHO’s Regional Director for the Eastern Mediterranean on COVID-19
Cairo, 22 December 2021 – A year ago, the COVID-19 vaccine rollout had brought us hope that we could end the acute phase of the pandemic by the end of 2021. Instead, as we enter the third year of the pandemic, the world remains very much in its grip. Globally, COVID-19 has so far claimed more than five million lives…
::Inequitable COVID-19 vaccination coverage in the Eastern Mediterranean Region is a missed opportunity to protect people from severe disease and death
Cairo, 20 December 2021– As 2021 comes to an end, the gap in COVID-19 vaccination coverage between countries of the Eastern Mediterranean Region widens alarmingly  As of 14 December 2021, over 500 million doses of COVID-19 vaccine have been administered in the Region, an average of 65 doses per 100 population. However, high- and upper-middle-income countries have administered about twice the…

WHO Western Pacific Region
No new digest content identified

 

::::::

WHO Events
https://www.who.int/news-room/events/2
[Selected]
19 January 2022
Extraordinary meeting of the Strategic Advisory Group of Experts on Immunization (SAGE) – 19 January 2022

13 January 2022
Seventh meeting of the WHO Council on the Economics of Health for All

11 January 2022
COVID-19 Case Management Webinar Series: COVID-19 and pregnancy

 

::::::

New WHO Publications
https://www.who.int/publications/i
Selected Titles
6 January 2022
Mekong Malaria Elimination: epidemiology summary, volume 15, July–September 2021

30 December 2021
Together on the road to evidence-informed decision-making for health in the post-pandemic era: a draft call for action
Overview
The EVIPNet Call for Action for sustainable evidence-policy-society-systems was launched at the WHO Global Evidence-to-Policy Summit in November 2021, and received wide encouragement and support from global partners, multisectoral stakeholders and EVIPNet members. Existing EVIPNet country teams and partner organizations will provide additional support taking the Call for Action forward.

23 December 2021
An implementation guide for the management of COVID-19 on board cargo ships and fishing vessels

22 December 2021
WHO recommendations on mask use by health workers, in light of the Omicron variant of concern: WHO interim…

22 December 2021
COVID-19 infection prevention and control living guideline: mask use in community settings, 22 December…

20 December 2021
Interim recommendations for use of the Novavax NVX-CoV2373 vaccine against COVID-19

20 December 2021

 

Annexes to the interim recommendations for use of the Novavax NVX-CoV2373 vaccine against COVID-19